Maurie Markman on Muck Rack

Maurie Markman

As seen in: OncLive, The Oncologist, Women's Health (SAGE Journal), Cancer Investigation, Scientific American, JAMA (The Journal of the American Medical Association), Nutrition Journal, Medscape, Medscape Noticias Médicas, Medscape PT, STAT and
President of Medicine and Science @CancerCenter #TreatThePerson #Oncology #Genomics #PrecisionMedicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maurie

Contact Maurie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Fast Five Quiz: Identify and Treat Melanoma

|
By William James, Maurie Markman
| Medscape
Melanoma is an aggressive cancer that poses a greater risk of spreading and mortality if not identified early. Its development is influenced by a complex interplay of genetic predisposition, skin type, and environmental factors such as ultraviolet (UV) radiation exposure. According to a recent review, fair complexion is a strong risk factor for melanoma because it provides less natural protection against UV radiation.
Open in Who Shared Issue with article?

Nursing Strategies to Combat Food Insecurity in Metastatic Breast Cancer

|
By Maurie Markman, Gina Mauro, Alex Biese 
| Oncology Nursing News
The environment in which a patient lives can be just as influential as their genetic code. At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, research led by Emily L. Podany, MD, of Washington University School of Medicine, demonstrated that patients with metastatic breast cancer (MBC) living in food deserts face more aggressive tumor biology and significantly shorter survival.
Open in Who Shared Issue with article?

Precision Prophylaxis: Managing Diverse ADC Safety Profiles at ASCO 2026

|
By Maurie Markman, Gina Mauro, Alex Biese 
| Oncology Nursing News
While the oncology community often groups antibody-drug conjugates (ADCs) under a single three-letter acronym, clinical management requires a far more nuanced approach. During an interview at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Paolo Tarantino, MD, of the Dana-Farber Cancer Institute, emphasized that the safety profiles of these agents are as diverse as the patients they treat.
Open in Who Shared Issue with article?
See all 278 licensed articles (519 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Maurie

Contact Maurie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified